# Untreated, Unresectable, or Metastatic Colorectal Cancer FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/untreated-unresectable-or-metastatic-colorectal-cancer

> 2 upcoming FDA catalysts in untreated, Unresectable, or Metastatic Colorectal Cancer: pumitamig (BMY) on Feb to May 2030 (topline data readout); pumitamig (BMY) on February 2030 (primary completion).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: quarter only, month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Feb to May 2030 | [Pumitamig topline data readout](https://sec-api.dev/pdufa/pumitamig) | BMY | Untreated, Unresectable, or Metastatic Colorectal Cancer | scheduled | "NCT07221357 (A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer): Overall Status RECRUITING; Phase PHASE2, PHASE3; Primary Completion 2030-02-02 (ESTIMATED); Lead Sponsor Bristol-Myers Squibb." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07221357)) |
| February 2030 | [Pumitamig primary completion](https://sec-api.dev/pdufa/pumitamig) | BMY | Untreated, Unresectable, or Metastatic Colorectal Cancer | scheduled | "NCT07221357 (A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer): Overall Status RECRUITING; Phase PHASE2, PHASE3; Primary Completion 2030-02-02 (ESTIMATED); Lead Sponsor Bristol-Myers Squibb." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07221357)) |

## Drugs

- [Pumitamig](https://sec-api.dev/pdufa/pumitamig) (BMY)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/untreated-unresectable-or-metastatic-colorectal-cancer.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Untreated, Unresectable, or Metastatic Colorectal Cancer FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/untreated-unresectable-or-metastatic-colorectal-cancer

```bibtex
@misc{secapidev_indications_untreated_unresectable_or_metastatic_colorectal_cancer_20261116,
  title        = {Untreated, Unresectable, or Metastatic Colorectal Cancer FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/untreated-unresectable-or-metastatic-colorectal-cancer}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_untreated_unresectable_or_metastatic_colorectal_cancer_20261116","title":"Untreated, Unresectable, or Metastatic Colorectal Cancer FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/untreated-unresectable-or-metastatic-colorectal-cancer","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
